Year : 2021 | Volume
: 4 | Issue : 3 | Page : 87-
COVID-19 endocrinology, adrenals, diabetes and obesity
Salem A Beshyah
Department of Medicine, Dubai Medical College, Dubai, UAE
Dr. Salem A Beshyah
PO Box 59472, Al Bateen, Abu Dhabi
|How to cite this article:|
Beshyah SA. COVID-19 endocrinology, adrenals, diabetes and obesity.J Diabetes Endocr Pract 2021;4:87-87
|How to cite this URL:|
Beshyah SA. COVID-19 endocrinology, adrenals, diabetes and obesity. J Diabetes Endocr Pract [serial online] 2021 [cited 2022 May 21 ];4:87-87
Available from: https://www.jdeponline.com/text.asp?2021/4/3/87/326372
Among the COVID-19 pandemic, many aspects of life have been put on the backburner, on the shelf or scraped completely. Fortunately, with this journal, we seem to be recovering albeit very slowly. As promised earlier in the year 2021, we are on the track. The third issue of this year is published well on time in its expected size with a variety of articles within the specialty.
The fear of getting out of date quickly is a rational cause for concern when one is writing anything about any aspect of COVID-19. Fortunately, in the current issue, a group of Gulf pituitary endocrinologists had put together a comprehensive narration of the literature on the pituitary gland in the COVID-19 pandemic by reviewing the literature up to the first half of the year. This review addressed the bidirectional relationship between COVID19 and the structure and function of the pituitary. The clinical values and research implications are highlighted in the accompanying commentary by Ngaosuwan and Johnston from the Imperial College London group. The second review is an update on diabetic kidney disease including pathogenesis and treatment overview for clinicians by Habas and colleagues from Doha (Qatar).
Four original articles are published in the issue. A proposal of new waist cut-off values to predict type 2 diabetes mellitus and hypertension risk in Arab adults is based on the WHO-steps data from Saudi Arabia. It is most likely applicable as well in the other oil-rich countries of the Gulf where both the genes and environment seem to be working similarly. Knowledge, beliefs, and practices of people with type 2 diabetes toward diabetes self-management and diabetic foot syndrome are presented by the colleagues from Oman. The Middle East and North Africa (MENA) Endocrine Research Group presents one of their Survey Monkey Project findings on the management of adrenal insufficiency from the results of their explorative survey of physicians' perceptions and practices from the MENA region. Shazia Hussein and colleagues, a group of British endocrinologists with interest in the challenges of managing adrenal insufficiency has provided a commentary on the article. Finally, we have a randomized controlled trial for efficacy of cardio-metabolic risk factor reduction with lifestyle intervention among corporate workers from Nigeria.
An interesting rare case of thyroid lymphoma is presented with discussion of the correlation of clinical, radiological, and pathological features in a focused review. Finally, Mohamed and Suliman summarized the highlights of the 81st Annual Conference of the American Diabetes Association held virtually in June 2021. We hope the readers find these contents both relevant and useful.